Journal of Animal Science and Technology

Korean Society of Animal Sciences and Technology (한국축산학회)
권호 표지
DOI QR코드

DOI QR Code

Gut microbiome-produced metabolites in pigs: a review on their biological functions and the influence of probiotics

  • Robie, Vasquez (Department of Animal Resources Science, Dankook University) ;
  • Ju Kyoung, Oh (Department of Animal Resources Science, Dankook University) ;
  • Ji Hoon, Song (Department of Animal Resources Science, Dankook University) ;
  • Dae-Kyung, Kang (Department of Animal Resources Science, Dankook University)
  • Received : 2022.06.10
  • Accepted : 2022.07.04
  • Published : 2022.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

The gastrointestinal tract is a complex ecosystem that contains a large number of microorganisms with different metabolic capacities. Modulation of the gut microbiome can improve the growth and promote health in pigs. Crosstalk between the host, diet, and the gut microbiome can influence the health of the host, potentially through the production of several metabolites with various functions. Short-chain and branched-chain fatty acids, secondary bile acids, polyamines, indoles, and phenolic compounds are metabolites produced by the gut microbiome. The gut microbiome can also produce neurotransmitters (such as γ-aminobutyric acid, catecholamines, and serotonin), their precursors, and vitamins. Several studies in pigs have demonstrated the importance of the gut microbiome and its metabolites in improving growth performance and feed efficiency, alleviating stress, and providing protection from pathogens. The use of probiotics is one of the strategies employed to target the gut microbiome of pigs. Promising results have been published on the use of probiotics in optimizing pig production. This review focuses on the role of gut microbiome-derived metabolites in the performance of pigs and the effects of probiotics on altering the levels of these metabolites.

Keywords

INTRODUCTION

Pig production is an economically important global industry [1]. A recent report from the European Union (EU) revealed that, in 2018, the pig production industry produced 148 million pigs, making pigs the largest livestock category in the region [2]. To meet the increasing demand, strategies for pig production have been developed to improve production yield, meat quality, profitability, and sustainability [3]. However, producers still face challenges related to increasing feed costs, poor growth performance, and the occurrence of diseases in pigs. Meanwhile, researchers have found a delicate relationship between the gut microbiome and the health and nutrition of pigs [4-6]. Consequently, the gut microbiome is a viable target for improving livestock production and increasing economic efficiency [3,4]. Dietary intervention is currently one of the primary strategies for targeting the gut microbiome of pigs. Recent evidence suggests that dietary intervention can modulate the gut microbiome and its metabolites and improve health and performance in pigs [7-9]. Optimization of feed and feed supplements has also resulted in increased survival rates of weaning piglets [10]. During the past decades, our knowledge of the role of gut microbiome in swine health and nutrition has expanded, from simple enhancement of nutrient absorption to the regulation of neurological functions. One of the mechanisms by which the gut microbiome affects the overall health of the host is through the production of metabolites [9,11]. Host recognition of microbiome-derived metabolites is integral to regulating and promoting pig health [6,11].

After the EU ban on antibiotic use in livestock production, dietary supplementation with probiotics has become a promising alternative to improve pig health and productivity [12,13]. Probiotic feeding has been shown to modulate the gut microbiome and alter its metabolite levels [9,14]. Moreover, it can also benefit livestock production, although some results have been inconsistent [12,15,16]. To date, our knowledge of gut microbiome-derived metabolites and their functional activities is limited, and the role of probiotics in modulating these metabolites is not well understood. In this review, the role of gut microbiome-derived metabolites in swine health and performance are discussed. In addition, this review summarizes recent studies demonstrating the effect of probiotics on these metabolites and their potential impact on pig production.

GUT MICROBIOME AND ITS METABOLITES

In recent years, our knowledge regarding the gut microbiome has greatly expanded owing to advancements in DNA sequencing technology and the availability of more powerful bioinformatics tools [9,14]. The gastrointestinal tract (GIT) consists of trillions of bacteria belonging to more than one thousand taxonomic groups, most of which are yet to be cultured and identified [11,17,18]. In addition to bacteria; viruses, archaea, fungi, and other eukaryotic microorganisms also reside in the gut of mammalian hosts and perform different functions in the GIT, thus creating an extremely complex and diverse ecosystem [9,11]. Until recently, the gut microbiome was regarded as an additional organ of the body owing to its role in the normal functioning of the host [19]. However, further examination reveals that the gut microbiome can be better identified as a part of a ‘holobiont’ with the host [20,21], and in the past few years, this intricate relationship between the gut microbiome and its host has been described extensively [20]. A bidirectional communication exists between the gut microbiome and the host, ultimately influencing health and disease pathogenesis (Fig. 1) [22,23]. For instance, the gut microbiome aids in nutrient absorption and regulation of intestinal barrier function [24]. The gut microbiome is also responsible for regulating intestinal immune function by stimulating anti-inflammatory regulatory T cells [11,23]. Moreover, the gut microbiome plays a key role in the enterohepatic circulation of bile acids and promotes cholesterol metabolism. The gut microbiome regulates the gut–brain axis, affecting host cognitive function and behavior [17,25,26]. Its modulating effect on host health can be attributed either through direct interaction with mucosal epithelial cells (IEC) or indirectly through the production of metabolites. Short-chain fatty acids (SCFAs), secondary bile acids, polyamines, indoles, and phenols are metabolites produced by gut microbiome during metabolism. Some of these metabolites are exclusively produced by the gut microbiome (such as SCFAs and secondary bile acids), while others are produced in conjunction with host cells. Different groups of commensal microorganisms contribute different metabolites to the overall metabolic pool of the host, and this is mainly due to differences in the fermentation capacities (i.e., different genes producing different enzymes) of each member of the gut microbiome. Thus, microorganisms in the gut do not act individually, but rather form consortia to produce these metabolites. The number and composition of the microbiome demonstrate spatial and temporal heterogeneity across the GIT, and the same is true for their metabolites [9,10,27]. For instance, most of the metabolites produced by the gut microbiome are generated in the colon, as most commensals reside there [28]. In addition, pigs of different ages have different gut microbiome composition [10]. These metabolites interact with the mucosal surface and trigger a host response [10,11]. Conversely, metabolites produced by the gut microbiome also influence other microorganisms in the gut; metabolites can either promote certain groups of microorganisms or inhibit their growth in the GIT [28]. Diet has a significant influence on gut microbiome and their metabolites. Dietary inclusion of fibers and various oligosaccharides has been found to increase the fermentation capacity of the gut microbiome to produce SCFAs [29–33]. Meanwhile, varying levels of crude protein in the diet influence amino acid fermentation by-products [24,34]. The mechanism by which these metabolites are produced, contributing microorganisms, and their impact on swine health are summarized in Table 1, and discussed in the following sections.

Table 1. Gut microbiome-produced metabolites, their biological functions, and their effects on pigs.

DMJGDA_2022_v64n4_671_t0001.png 이미지

DMJGDA_2022_v64n4_671_f0001.png 이미지

Fig. 1. Microbiome-derived metabolites and their effects on swine health. The gut microbiome, influenced by diet, produces various metabolites. SCFAs, bile acids, by-products of amino acid metabolism (BCFAs, polyamines, indolic compounds, and phenolic compounds), neurotransmitters, and vitamins are some of the metabolites produced by the gut microbiome. These metabolites are responsible for regulating intestinal health, immune function, metabolism, intestinal homeostasis, and cognitive function. However, high levels of some metabolites, such as ammonia and hydrogen sulfide, may not be beneficial to the host. Ultimately, the gut microbiome and its metabolites affect the growth performance, feed efficiency, and overall health of pigs. GABA, γ-aminobutyric acid; 5-HT, 5-hydroxytryptamine; BCFA, branched-chain fatty acid; SCFA, short-chain fatty acid; GPR/TGR, G-protein-coupled receptor; AhR, aryl hydrocarbon receptor; ATP, adenosine triphosphate; GLP-1, glucagon-like peptide 1; PYY, peptide YY; TNF, tumor necrosis factor; IL, interleukin; FXR, Farnesoid X receptor.

Short-chain fatty acids, branched-chain fatty acids, and lactate

SCFAs are fermentation by-products of indigestible polysaccharides, such as fiber and resistant starch, produced by the gut microbiome [38,111–113]. Amino acid fermentation, on the other hand, yields branched-chain fatty acids (BCFAs) [61,114,115]. Acetate, butyrate, and propionate are the major SCFAs produced in the gut, whereas isobutyrate and isovalerate are the main BCFAs in the GIT [61,114]. Lactate, on the other hand, is produced by lactic acid bacteria and utilized by SCFA-producing microbiota via a metabolite cross-feeding mechanism [63,64]. In pigs and other non-ruminant hosts, SCFA and BCFA concentrations along the intestinal tract exhibit heterogeneity, with the highest concentrations produced in the proximal colon [42,64,115,116]. Absorption of these metabolites occurs mainly in the colon [46]. The mechanism by which SCFAs are produced by the gut microbiome, either by anaerobic fermentation or cross-feeding, has been described extensively in previous publications [38,41,63,117,118]. Dietary fibers and gut microbiome composition greatly modulate these mechanisms [6,119]. Because dietary fibers are complex substrates, their complete degradation requires different members of the gut microbiome working in consortia to produce SCFAs [29,33,113]. The phylum Bacillota (Firmicutes) includes many SCFA-producing members, such as Ruminococcaceae and Lachnospiraceae [37,38]. Faecalibacterium, Eubacterium, Roseburia, Blautia, and Ruminococcus can produce SCFAs, particularly butyrate [29,33,35,36]. Clostridium also participates in the production of SCFAs, particularly acetate, in the swine gut [39]. Members of the phylum Actinobacteria, such as Bifidobacterium, and Bacteroidetes, such as Bacteroides fragilis, contribute to the SCFA pool by producing acetate, propionate, and butyrate [40–42]. Although most major SCFA producers in the gut have been characterized, there could be more unknown gut microbial residents involved in SCFA production. On the other hand, lactate is mainly produced by lactic acid bacteria and bifidobacteria from carbohydrate fermentation [120–122]. Meanwhile, in diets low in fiber, the gut microbiome shifts from SCFA to BCFA production, an adaptive mechanism to yield energy [114]. Clostridium, Propionibacterium, Streptococcus, and Bacteroides are the most common producers of BCFAs [61,62].

In recent years, many studies have demonstrated the role of SCFAs, especially butyrate, propionate, and acetate, in maintaining swine gut health [46]. Butyrate, the major energy source for colonocytes, has been extensively studied because of its anti-inflammatory ability and its effects on energy metabolism and homeostasis [44,45,123]. Butyrate also enhances enterocyte proliferation and reduces apoptosis [46]. Zhong et al. reported that enrichment of Lactobacillaceae and Ruminococcaceae also elevates butyrate concentrations, which in turn regulates gut homeostasis by stimulating cell proliferation and suppressing pro-inflammatory cytokines [47]. In addition, Han et al. demonstrated that butyrate reduces pro-inflammatory cytokines interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)α, IL-8, and IL-12 and protects colon morphology against lipopolysaccharide (LPS)-induced colitis in weaning pigs [48]. Butyrate supplementation also alleviates diarrhea and upregulates tight-junction (TJ) proteins, such as claudin-3, occludin, and ZO-1, in weaning pigs [49]. Meanwhile, propionate has been reported to decrease serum and liver triglyceride levels and improve lipid metabolism in growing pigs [124]. Similar to butyrate, Zhang et al. reported that propionate increased jejunal expression of TJ proteins claudin-1, claudin-4, and occludin in pigs [50]. Propionate also promotes regulatory T cell (Treg) proliferation and regulates their function, resulting in colonic homeostasis [51]. Tregs play a crucial role in suppressing the immune response and their differentiation and potentiation are highly influenced by SCFA activation of G-protein-coupled receptor 43 (GPR43) [125–127]. Acetate, on the other hand, reduces inflammation by suppressing activation of inflammasomes via GPR43 [52]. The beneficial effects of SCFAs on intestinal health may also improve growth performance in pigs. In separate studies, Reyer et al. and McCormack et al. reported that pigs with high feed efficiency ([FE], leaner pigs) are associated with a higher abundance of SCFA-producing microbiota, such as Christensenellaceae, Oscillibacter, Cellulosilyticum, Rothia, Subdoligranulum, and Leeia [53,54]. Infusion of SCFAs in growing pigs resulted in higher feed intake and daily gain, as well as improved carcass and meat quality [55]. Furthermore, Gardiner et al. posited that microbiome-derived SCFAs promote insulin sensitivity and satiety in pigs, through GPR-activated stimulation of glucagon-like peptide-1 (GLP-1) and peptide YY secretion resulting in lower feed intake [6]. Meanwhile, lactate produced by lactic acid bacteria and Bifidobacteria helps to reduce the pH of the GIT, preventing the growth of potentially pathogenic bacteria, such as enterotoxigenic Escherichia coli [120].

BCFAs are produced through the deamination of the branched-chain amino acids valine, leucine, and isoleucine [60,62]. The BCFA concentration serves as a marker for protein fermentation, although it is also affected by the level of dietary carbohydrates [61,62,87,128]. In pigs fed with low dietary fiber, Heo et al. observed a decrease in the levels of BCFAs [129], while the addition of resistant starch also decreased BCFA levels [130]. Similar to butyrate, BCFAs can also be utilized by colonocytes as an energy source, although they are not preferred sources [56]. In previous studies, BCFAs were thought to have a protective function against inflammation in the premature intestine [57,58]. Moreover, BCFAs show a dose-dependent ameliorating effect against the pro-inflammatory cytokines TNFα and interferon (IFN)γ in pigs [59]. However, BCFAs are often associated with other byproducts of protein fermentation, such as ammonia and hydrogen sulfide, and are thus considered potentially harmful metabolites [60,131,132]. BCFAs can impair gut barrier function and enhance the expression of pro-inflammatory cytokines [60]. Nevertheless, additional evidence is required to determine the exact role of BCFAs in intestinal health.

Bile acids

Bile acids are hydroxylated amphipathic steroid acids produced from the liver via cholesterol metabolism [71,73]. In the normal state, bile acid plays an integral role in digestion, lipid absorption, and cholesterol and fat-soluble vitamins uptake [133]. Primary bile acids are produced from the conjugation of bile acids produced in the liver with taurine or glycine (also referred to as conjugated bile acids) [71,133]. The majority (95%) of primary bile acids are reabsorbed in the distal ileum via enterohepatic circulation. However, a small portion of these primary bile acids escapes, flows into the colon, and is metabolized by the microbiome into secondary bile acids [71,73,133]. Gut resident microbiota, such as Lactobacillus, Clostridium, Bacteroides, Bifidobacterium and Enterococcus can deconjugate taurine or glycine from the conjugated bile acids via bile salt hydrolase (BSH) enzyme to produce free primary acids in the colon [74,134]. These primary bile acids are then transformed into secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid (LCA) via 7α-hydroxylation. Members of the Clostridium genus, such as Clostridium hiranonis, C. hylemonae, C. sordellii, and C. scindens, and genus Eubacterium are known to possess the bile acid-inducible (bai) operon, which is responsible for the 7α-hydroxylation activity of these genera [71–74]. There is a bidirectional interaction between bile acids and the gut microbiome – the gut microbiome metabolizing primary bile acids to produce secondary bile acids effectively alters the bile acid pool, while the secondary bile acids regulate the gut microbiome composition through their antimicrobial and cytotoxic activities [28,74,134,135].

According to recent studies, both primary and secondary bile acids interact with nuclear hormone receptors, specifically the Farnesoid X receptor (FXR) or G protein-coupled receptor (TGR5) [65,71]. This interaction is highly dependent on the affinity of each bile acid for the receptors [71]. Bile acid activation of TGR5 plays specific roles in glucose homeostasis (through the production of GLP-1), energy homeostasis, and inhibition of proinflammatory cytokines, whereas FXR activation contributes to the regulation of bile acid synthesis and lipid metabolism [65–67]. However, in dysbiosis, the normal interactions between bile acids and the gut microbiome are altered such that bile acids, especially secondary bile acids, can negatively impact swine intestinal health. Previous in vitro studies in porcine cells have demonstrated that excessive secondary bile acids, particularly LCA and DCA, decreased cell proliferation and gene expression of TJ proteins [68,69]. Moreover, Lin et al. showed that LCA downregulated the gene expression of catalase and superoxide dismutase, which are integral for relieving oxidative stress [69]. Although in vivo experiments focusing on swine bile acid profiles and microbiomes are limited, the results from these studies echo what has been observed in vitro. During a state of undernutrition in piglets, an increase in secondary bile acid concentration was observed, together with a decreased relative abundance of Lactobacillus [68]. Similarly, hyodeoxycholic acid (HDCA) feeding downregulated the expression of proliferating cell nuclear antigen (PCNA) and cyclin D1, markers of epithelial cell proliferation, in the ileum of weaning pigs, while enriching the population of known secondary bile acid producers such as Parabacteroides, Clostridia family XII TCG-001, and Lachnospiraceae [70]. These results suggested that bile acid metabolism in the gut microbiome is a potential target for improving swine health. However, the current data are still limited and thus require further investigation.

Polyamines

Polyamines are low-molecular-weight polycationic molecules produced by the gut microbiome through decarboxylation of aromatic or cationic amino acids [76,136]. Polyamines are important microbiome-derived metabolites, which play crucial roles in gene regulation, signal transduction, DNA and protein synthesis, protection against oxidative stress, and cell proliferation and differentiation [76,77,81,136]. Host colonocytes can produce polyamines (unlike SCFAs); however, the gut microbiome can also significantly contribute to the polyamine profile [87,88]. Putrescine, spermine, and spermidine are the main polyamines produced by the gut microbiome, whereas cadaverine, histamine, tyramine, and 5-aminovalerate are also produced in smaller amounts [77]. In the gut, numerous bacterial groups can metabolize amino acids into polyamines, including Clostridium XIVa group, Roseburia, and Ruminococcus [75]. Bacteroides and Fusobacterium also contribute to polyamine production in the large intestine [76,77]. Enterococcus, Streptococcus, Clostridium, Lactococcus, and Lactobacillus use anaerobic pathways to produce polyamines [77]. Bifidobacterium also has the capacity to produce polyamines [78]. Since these bacteria do not always have a complete set of enzymes to produce polyamines, the colonic microbiome is thought to work collectively to produce polyamines [138]. The polyamine concentration in pig intestines is highly influenced by the dietary protein levels [34,128,139]. Yu et al. reported that extremely low dietary protein levels result in lower tryptamine, cadaverine, and putrescine levels in pigs [140]. Similarly, Chen et al. demonstrated that a reduction in dietary protein from 18% to 12% reduces both ileal and colonic polyamine concentrations in growing pigs [141]. In contrast, a low protein diet enhances polyamine production. For instance, in a low-protein diet with antibiotic treatment, researchers have observed elevated polyamine concentrations in pigs [142,143]. In addition, Peng et al. reported that reduction of dietary crude protein to 15.3% increased total polyamines, especially cadaverine, but decreased upon further dietary protein reduction [144]. These contradictory results may be due to the presence of the amino acid lysine (precursor of cadaverine) even in the low-protein diet, as most researchers have noted in their respective reports.

To date, multiple studies have demonstrated the beneficial effects of polyamines on intestinal health in pigs. Polyamines (mainly putrescine, spermidine, and spermine) regulate swine gestation—they promote placental development, stimulate blastocyst formation, and inhibit apoptosis, potentially improving the survival of the fetus [80,81,145]. Polyamines are also crucial in the growth and maturation of the small intestine in early weaned piglets, as demonstrated by a series of studies [79,82–84]. Fang et al. reported that spermine enhances oxidative stress resistance in piglets [82]. Piglets fed spermine and spermidine-supplemented feed showed increased growth compared to those fed a normal diet, as reported by van Wettere et al. [83]. Lui et al. demonstrated that putrescine alleviates diarrhea and suppresses the expression of TNF-α, IL-6, and IL-8 in weaning piglets [146]. In contrast, Ewtushik et al. observed that polyamines caused detrimental damage to the intestinal morphology of early weaned piglets, which may be due to the concentrations and ratios of polyamines used in the experiment [85].

Indolic and phenolic metabolites

In addition to BCFAs and polyamines, microbial metabolism of amino acids also produces indolic and phenolic compounds [56,87,147]. These metabolites are produced by fermentation of tryptophan, tyrosine, and phenylalanine. Indole and indoleacetate are produced from the microbial fermentation of tryptophan, whereas tyrosine fermentation yields phenol, p-cresol, and 4-ethylphenol [87,88,94,147]. While phenylalanine fermentation produces phenylacetate and phenylpropionate [94]. High concentrations of indolic and phenolic compounds are produced in the distal colon, where the pH is near neutral and is favorable for the fermentation process to occur [56,87,147]. Amino acid fermentation is highly affected by dietary protein content; as such, elevated concentrations of indole and phenol have been observed in pigs fed a high-protein diet [56,62,132]. Anaerobic bacteria in the colon, such as Bacteroides, Clostridium, Peptostreptococcus, Bifidobacterium, Lactobacillus, and Escherichia are known to be involved in amino acid fermentation [86–88]. For instance, Clostridium sporogenes and Clostridium botulinum can produce indolepropionic acid through tryptophan metabolism [89]. Similarly, Peptostreptococcus contains phenyllactic acid dehydratase, which is responsible for the production of indole-3-acrylate [90]. Lactobacillus produces indole-3-aldehyde and indoleacetic acid from tryptophan [86]. Bifidobacterium can ferment tryptophan into indolelactic acid. Indolic compounds produced by the microbial fermentation of amino acids serve important functions in maintaining colonic health. Indolic compounds are important in stimulating the gut mucosal barrier through the activation of aryl hydrocarbon receptors (AhR) in intestinal epithelial cells [91,92] and upregulating the expression of TJ proteins such as claudin. Indole and its derivatives, such as indolepropionic acid, also reduce inflammation by activating the pregnane X receptor (PXR) [92,148]. In contrast, phenol and its derivatives exert deleterious effects on intestinal homeostasis. Phenol increases gut permeability, whereas p-cresol disrupts colonic cell respiration and ATP synthesis [60,93,94].

Among aromatic amino acids, tryptophan metabolism is perhaps the most studied in relation to pigs because the by-products of tryptophan fermentation, such as indolepropionic acid and indoleacetic acid, confer beneficial health effects [148]. In weaned piglets, increased colonic levels of microbiome-produced indole and indoleacetic acid coincided with the upregulation of AhR and increased TJ proteins ZO-1 and occludin [95]. Liang et al. reported that L-tryptophan supplementation improved the intestinal mucosal barrier of weaned pigs by upregulating ZO-1, ZO-3, and claudin-1, which were linked to the increased population of tryptophan-fermenting commensal bacteria Clostridium and Lactobacillus [150]. Indole and its derivatives also attenuate oxidative stress in diquat-treated pigs, as reported by Fu et al. [96]. On the other hand, skatole, like indole, is also a product of microbial fermentation of tryptophan and is associated with the occurrence of undesirable odor and meat taste called ‘boar-taint’ in barrows [97,98]. In their review, Wesoly and Weiler identified Clostridium and Bacteroides as the main commensal bacteria responsible for skatole formation [97]. Pieper et al. reported that skatole, together with tyrosine-derived products phenol and p-cresol, was elevated by high-protein diets [99]. They also noted that p-cresol negatively affected the growth performance of pigs [99].

Ammonia and hydrogen sulfide

Ammonia and hydrogen sulfide are also produced during the microbial fermentation of amino acids in the distal colon [87,103]. Bacterial production of ammonia involves either deamination of amino acids or hydrolysis of urea through ureases [56,88,132]. Several studies have focused on the role of Helicobacter pylori and H. suis in the production of ammonia during glutamine deamination in both humans and pigs [100,101]. Ammonia is considered a toxic fermentation by-product; thus, it is converted back to urea via enterohepatic circulation and excreted in urine [132]. In pigs, as well as in other hosts, a high-protein diet increases the production of ammonia; conversely, decreasing the protein or including fiber in the diet reduces ammonia production [56,103,151,152]. In a high-protein diet, where ammonia production is elevated, ammonia inhibits mitochondrial oxygen consumption and SCFA oxidation [87]. In addition, ammonia impedes the intestinal uptake of butyrate by downregulating monocarboxylate transporter 1 (a transporter protein) [56], which may explain the impaired protective effect of butyrate during increased ammonia levels [60]. However, the deleterious effect of ammonia is dose-dependent and usually requires higher concentrations to cause negative effects, as pointed out by Gilbert et al. [56]. Fermentation of methionine and cysteine, on the other hand, produces hydrogen sulfide [87,88,102]. Fusobacterium, Desulfovibrio, Escherichia, Salmonella, Clostridium, and Enterobacter have been reported to produce hydrogen sulfide from sulfur-containing amino acids [88,102]. These bacteria possess desulfhydrases that utilize these amino acids for energy [87]. Like ammonia, the effect of hydrogen sulfide on the host depends on its concentration. Hydrogen sulfide acts as an energy substrate for colonocytes and a signaling molecule at low micromolar levels; in contrast, at low millimolar levels, it inhibits cytochrome oxidase activity in the mitochondria [102,103]. At high concentrations, hydrogen sulfide can also hinder cell proliferation and induce intestinal inflammation [102]. The effects of gut microbiome-produced ammonia and hydrogen sulfide on the growth performance and intestinal health of pigs are not yet fully understood and require further investigation.

Neurotransmitters

Neurotransmitters are important molecules in the central nervous system as they carry signals that control behavior and cognition [17]. These molecules can be either excitatory (glutamate, dopamine, and acetylcholine) or inhibitory (γ-aminobutyric acid [GABA], norepinephrine, and serotonin). In pigs, environmental stress factors (such as handling, housing, and weaning) have been known to affect the levels of neurotransmitters [153–155]. The gut microbiome regulates the gut–brain axis by producing these neurotransmitters or their precursors [17,25,26,104]. Some gut microorganisms, such as E. coli, Pseudomonas, and other known pathogens, also utilize these neuroactive metabolites as energy sources [104,110]. Strandwitz summarized most neurotransmitter-producing bacteria, such as Bifidobacterium and Lactobacillus (GABA), Bacillus and Escherichia (dopamine), Escherichia, Klebsiella, and Lactobacillus (serotonin) [104]. Biosynthesis of serotonin (5-hydroxytryptamine [5-HT]) by enterochromaffin cells is highly regulated by gut microbiome, specifically spore-forming bacteria [156,157]. Lactic acid bacteria are also known to produce trace amines (neuromodulating metabolites), including tyramine and tryptamine [17,26]. Notably, microbiome-produced neurotransmitters cannot cross the blood–brain barrier; thus, they act locally on the enteric nervous system or vagus nerves (in the case of GABA) or enteric dopaminergic neurons (in the case of dopamine) [17,104,158]. On the other hand, precursors of these neurotransmitters can cross the blood–brain barrier and influence the biosynthesis of neurotransmitters in the brain. The SCFA acetate traverses the blood–brain barrier into the hypothalamus and affects the biosynthesis of glutamate and GABA in the host [17]. Gut microbiome dysbiosis can lead to altered microbial production of neurotransmitters and their precursors, thus affecting behavior and cognition in pigs. In antibiotic-treated pigs, modulation of colonic microbiome leads to a significant reduction in neurotransmitters [159]. There is also significant evidence that altered gut microbiome and tryptophan-serotonin metabolism are associated with tail biting in pigs [105]. In contrast, dietary supplementation with tryptophan has been shown to alter the bacterial production of serotonin [106,107]. These studies emphasize the role of gut microbiome and diet in the biosynthesis of neurotransmitter chemicals, which ultimately affects neurological function in pigs.

Vitamins

Similar to the human gut microbiome, the pig gut microbiome can also synthesize vitamins [6,159,160]. Members of the genus Bacteroides are the main producers of water-soluble vitamin B, including riboflavin, thiamine, biotin, cobalamin, and folates [160,161]. Some species of Lactobacillus also have the capacity to de novo synthesize vitamin B [108,109]. B vitamins serve as coenzymes in neurological processes [110]. Vitamin K, an essential vitamin for proper blood clotting, is produced by the gut microbiome as well [108,110]. These gut microbiome-derived vitamins support the functional metabolism not only of the hosts, but also of other non-vitamin producing bacteria, such as Faecalibacterium, thereby extending their influence on intestinal health [161,162]. Our knowledge of the extent of the effects of gut microbiome-synthesized vitamins on pigs is still scarce and must be investigated in the future.

INFLUENCE OF PROBIOTICS SUPPLEMENTATION ON MICROBIAL METABOLITES

Probiotics, as defined by the FAO/WHO, are live microorganisms that, when administered in adequate amounts, confer health benefits to the host [13,164]. Since the ban on the use of antibiotics as animal growth promoters, the use of probiotics in livestock production has been steadily on the rise [12,13]. In swine production, the most common probiotic species used are Lactobacillus, Bacillus, Clostridium, Bifidobacterium, Enterococcus, and Saccharomyces [16,164-166]. To date, there is abundant evidence demonstrating the beneficial effects of probiotics on swine health and growth. Probiotic supplementation in pigs has been shown to improve average daily weight gain (ADG) and FE, stimulate the immune system, protect the host from pathogen invasion, improve nutrient digestion, and modulate gut microbiome [12,16,164,165,167,168]. The role of probiotics in swine maternal health, improving health in early life stages, and alleviating weaning stress in piglets has been highlighted in previous studies [169,170].

Probiotic supplementation affects gut microbiome composition and microbiome-derived metabolites (Fig. 1). Probiotics generally increase the concentrations of SCFAs, particularly acetate, butyrate, and propionate, in pigs [122,171–178]. Lactate levels can also be increased by probiotic supplementation due to the abundance of lactic acid bacteria [122,173]. The elevation in SCFA concentration was correlated with changes in the composition of the gut microbiome. Probiotic supplementation in pigs preferentially enriches the phylum Firmicutes, which consists of SCFA-producing bacterial groups, such as Lactobacillaceae, Ruminococcaceae, Erysipelotrichaceae, and Lachnospiraceae [122,171,175,178–180]. Furthermore, probiotic-mediated changes in the SCFA profile is associated with positive effects on the pigs, such as improved growth performance [171,172,174,175,178], improved intestinal morphology [176–178], stimulation of the host’s immunity [171,174], protection against pathogens [181], and improvement of cognitive performance [173]. The enhancing effect of probiotics on the SCFA profile of pigs is attributed to the increased ability of the gut microbiome to metabolize carbohydrates [182,183]. Probiotic-mediated elevation of Lactobacillus and Bifidobacterium in the GIT contributes to the elevation of SCFA levels, as these bacteria are known to generate SCFAs [16,161,183]. Lactate production also contributes to SCFA levels, specifically butyrate, through the cross-feeding mechanism of other commensals [112,184]. In contrast, studies on the effect of probiotics on the bile acid profile of pigs are currently limited. Nevertheless, data support the idea that probiotics can potentially alter the bile acid profile of pigs. Feeding of Lactobacillus plantarum to weaning piglets decreased the concentration of secondary bile acid secondary bile acid (LCA) in the ileum and increased the relative abundance of Lactobacillus while reducing the population of Clostridium and Parabacteroides [69]. Likewise, dietary supplementation with Lactobacillus delbrueckii proved to be efficient in lowering both primary and secondary bile acids in growing-finishing pigs [185]. Nealon et al. observed that Lactobacillus rhamnosus GG, combined with E. coli Nissle and rice bran, altered bile acid metabolism in pigs challenged with human rotavirus [186]. Additionally, the same authors highlighted the role of bile acids in the regulation of diarrhea, especially the secondary bile acid hyodeoxycholic acid (HDCA) [186]. The modulating effect of probiotics on the bile acid profile of swine may be attributed to the BSH activity of these probiotic strains, as well as their enriching effect on other gut resident microbiota with BSH activity, which promotes fecal excretion and neosynthesis of bile acids [135,185,187,188]. Another potential mechanism by which probiotics influence the bile acid profile is by reducing the population of gut clostridial species and other species known to produce secondary bile acids [69,178].

Microbial metabolites from amino acid fermentation (BCFAs, polyamines, indolic and phenolic compounds, and ammonia) are also influenced by probiotic feeding. Barba-Vidal et al. and Rodrigues-Sorrento et al. reported a reduction in colonic ammonia levels after supplementation with Bifidobacterium longum subsp. infantis in piglets challenged with ETEC K88 [189] or ETEC F4 [190] Meanwhile, probiotic feeding in pigs reduces skatole concentrations, as observed in multiple studies [177,180,191]. Similarly, supplementation of either Bacillus subtilis DSM 32315 with xylooligosaccharides (XOS) or a combination of Lactobacillus plantarum B90 and Saccharomyces cerevisiae P11 decreased indole concentrations [176,180]. Meanwhile, the effect of probiotics on polyamine levels is not always consistent, as observed in a series of studies [176,180,186], except for putrescine, which was consistently reduced by probiotic supplementation. Changes in amino acid fermentation metabolites always corresponds to changes in the composition of the gut microbiome; thus, modulation of the gut microbiome composition could be the main mechanism by which probiotics alter these metabolites [132,192]. Enrichment of beneficial bacteria, such Lactobacillus, Bacteroides, Bacillus, and SCFA-producing commensals, improves the enzymatic activities of digestive proteases and peptidases and increases the absorption ability of the epithelium [132,192]. In addition, probiotic consumption could offer protection from pathogenic and skatole-producing bacteria, such as E. coli through competitive exclusion or the production of antimicrobial peptides, such as bacteriocins [192]. Furthermore, probiotics potentially encourage the assimilation of ammonia into bacterial proteins, thereby reducing its excretion [132].

Probiotics can also be used to target the microbiome–gut–brain axis. Probiotics modulate the production of neurotransmitters in the gut, thereby modulating the signaling patterns in the gut–brain axis [193,194]. In rats, supplementation with L. rhamnosus JB-1 alters the levels of neurotransmitters such as GABA and glutamate, suggesting an underlying mechanism for the probiotic modulation of these chemicals. Currently, the use of probiotics to target the microbiome–gut–brain axis in pigs is limited. Based on the effects of probiotics on neurotransmitters and precursors in humans and other animal models, it is suspected that the effects might be similar in pigs. Indeed, Cao et al. reported that supplementation with Clostridium butyricum-based probiotics altered the levels of neurotransmitters (such as 5-HT, GABA, and dopamine) in weaned piglets [195]. Moreover, Bifidobacterium breve CECT8242 reverses the reducing effect of a high-fat diet on the neurotransmitter profiles of pigs [196]. A symbiotic preparation containing Lactobacillus salivarius and Lactobacillus reuteri improved the cognitive functions of pigs (although the authors did not measure changes in neurotransmitters in the study) [197]. Supporting investigations are still necessary to determine the potential of probiotics to affect the microbiome–gut–brain axis and their long-term effects on the pig production industry.

Notably, the beneficial effects of probiotics on the gut microbiome-derived metabolites are not consistently observed. For example, Nowak et al. did not observe any changes in the levels of indole, phenol, or p-cresol after supplementation with multispecies probiotics (Leuconostoc mesenteroides, Enterococcus faecium, and Carnobacterium divergens) [198]. Similarly, probiotic feeding did not change SCFA levels, as observed by Zhang et al. with Clostridium butyricum supplementation [199]. Conversely, changes in the microbiome and their metabolites may not always correspond to improvements in growth performance, FE, and other performance indices, as observed in multiple studies [122,173,191]. The inconsistencies in the observations of different studies may be attributed to several factors, including, but not limited to, the type of probiotics used (strain/species, single/multiple species), dose, age of pigs (neonatal, weaning, or finishing), duration of supplementation, other dietary components (fibers, protein concentration), husbandry practices, and varying environmental factors [16,167]. In addition to the potential reasons for the inconsistencies in reports, Ohashi and Ushida also noted that the effect of probiotics is significantly affected by the response of the indigenous gut microbiome [183]. Therefore, a careful approach must be exercised when selecting probiotics for pig production. A vast knowledge of the underlying mechanism of probiotics on swine gut microbiome and their metabolites is necessary to anticipate their overall impact on pig performance and health.

CONCLUSIONS

The significance of gut microbiome in modulating host health cannot be denied. Gut microbiomederived metabolites, such as SCFAs, BCFAs, secondary bile acids, polyamines, indolic and phenolic compounds, and various neurotransmitters play crucial roles in maintaining and improving swine health. The effect of these metabolites can be beneficial or, in the state of dysbiosis or stress, deleterious to pigs. Thus, targeting the gut microbiome to modulate their metabolites is a key strategy for improving the growth of livestock animals. The dietary inclusion of probiotics can significantly alter the gut microbiome and the metabolites produced by it. Probiotics influence the production of metabolites by the gut microbiome. However, the effects of probiotics depend on many factors, and the results may not be consistent, as highlighted in this review. A comprehensive assessment must be conducted before supplementation with specific probiotics or probiotic combinations. Moreover, there is still a gap in the existing knowledge regarding the degree of the effects of gut microbiome-derived metabolites on swine health. In vitro and in vivo investigations of the mechanistic actions of these metabolites are extremely valuable for understanding their overall effects on pig health and growth. In addition, multi-omics techniques may provide valuable information on the complex interactions among the gut microbiome, metabolites produced by it, and swine health.

References

  1. Woonwong Y, Tien DD, Thanawongnuwech R. The future of the pig industry after the introduction of African swine fever into Asia. Anim Front. 2020;10:30-7. https://doi.org/10.1093/af/vfaa037
  2. Augere-Granier ML. The EU pig meat sector. Cardiff: European Parliamentary Research Service; 2020. Report No.: PE 652.044.
  3. Maltecca C, Bergamaschi M, Tiezzi F. The interaction between microbiome and pig efficiency: a review. J Anim Breed Genet. 2020;137:4-13. https://doi.org/10.1111/jbg.12443
  4. Bergamaschi M, Tiezzi F, Howard J, Huang YJ, Gray KA, Schillebeeckx C, et al. Gut microbiome composition differences among breeds impact feed efficiency in swine. Microbiome. 2020;8:110. https://doi.org/10.1186/s40168-020-00888-9
  5. Oh JK, Chae JP, Pajarillo EAB, Kim SH, Kwak MJ, Eun JS, et al. Association between the body weight of growing pigs and the functional capacity of their gut microbiota. Anim Sci J. 2020;91:e13418. https://doi.org/10.1111/asj.13418
  6. Gardiner GE, Metzler-Zebeli BU, Lawlor PG. Impact of intestinal microbiota on growth and feed efficiency in pigs: a review. Microorganisms. 2020;8:1886. https://doi.org/10.3390/microorganisms8121886
  7. Wang X, Tsai T, Deng F, Wei X, Chai J, Knapp J, et al. Longitudinal investigation of the swine gut microbiome from birth to market reveals stage and growth performance associated bacteria. Microbiome. 2019;7:109. https://doi.org/10.1186/s40168-019-0721-7
  8. Jiang H, Fang S, Yang H, Chen C. Identification of the relationship between the gut microbiome and feed efficiency in a commercial pig cohort. J Anim Sci. 2021;99:skab045. https://doi.org/10.1093/jas/skab045
  9. Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial ecology along the gastrointestinal tract. Microbes Environ. 2017;32:300-13. https://doi.org/10.1264/jsme2.ME17017
  10. Pluske JR, Turpin DL, Kim JC. Gastrointestinal tract (gut) health in the young pig. Anim Nutr. 2018;4:187-96. https://doi.org/10.1016/j.aninu.2017.12.004
  11. Sun X, Jia Z. Microbiome modulates intestinal homeostasis against inflammatory diseases. Vet Immunol Immunopathol. 2018;205:97-105. https://doi.org/10.1016/j.vetimm.2018.10.014
  12. Zimmermann JA, Fusari ML, Rossler E, Blajman JE, Romero-Scharpen A, Astesana DM, et al. Effects of probiotics in swines growth performance: a meta-analysis of randomised controlled trials. Anim Feed Sci Technol. 2016;219:280-93. https://doi.org/10.1016/j.anifeedsci.2016.06.021
  13. Barba-Vidal E, Martin-Orue SM, Castillejos L. Practical aspects of the use of probiotics in pig production: a review. Livest Sci. 2019;223:84-96. https://doi.org/10.1016/j.livsci.2019.02.017
  14. Kim HB, Isaacson RE. The pig gut microbial diversity: understanding the pig gut microbial ecology through the next generation high throughput sequencing. Vet Microbiol. 2015;177:242-51. https://doi.org/10.1016/j.vetmic.2015.03.014
  15. Ding S, Yan W, Ma Y, Fang J. The impact of probiotics on gut health via alternation of immune status of monogastric animals. Anim Nutr. 2021;7:24-30. https://doi.org/10.1016/j.aninu.2020.11.004
  16. Valeriano VDV, Balolong MP, Kang DK. Probiotic roles of Lactobacillus sp. in swine: insights from gut microbiota. J Appl Microbiol. 2017;122:554-67. https://doi.org/10.1111/jam.13364
  17. Chen Y, Xu J, Chen Y. Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients. 2021;13:2099. https://doi.org/10.3390/nu13062099
  18. Chen C, Zhou Y, Fu H, Xiong X, Fang S, Jiang H, et al. Expanded catalog of microbial genes and metagenome-assembled genomes from the pig gut microbiome. Nat Commun. 2021;12:1106. https://doi.org/10.1038/s41467-021-21295-0
  19. Baquero F, Nombela C. The microbiome as a human organ. Clin Microbiol Infect. 2012;18:2-4. https://doi.org/10.1111/j.1469-0691.2012.03916.x
  20. Simon JC, Marchesi JR, Mougel C, Selosse MA. Host-microbiota interactions: from holobiont theory to analysis. Microbiome. 2019;7:5. https://doi.org/10.1186/s40168-019-0619-4
  21. Riccio P, Rossano R. The human gut microbiota is neither an organ nor a commensal. FEBS Lett. 2020;594:3262-71. https://doi.org/10.1002/1873-3468.13946
  22. Brody H. The gut microbiome. Nature. 2020;577:S5. https://doi.org/10.1038/d41586-020-00194-2
  23. Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015;31:69-75. https://doi.org/10.1097/MOG.0000000000000139
  24. Chalvon-Demersay T, Luise D, Le Floc'h N, Tesseraud S, Lambert W, Bosi P, et al. Functional amino acids in pigs and chickens: implication for gut health. Front Vet Sci. 2021;8:663727. https://doi.org/10.3389/fvets.2021.663727
  25. Jenkins TA, Nguyen JCD, Polglaze KE, Bertrand PP. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients. 2016;8:56. https://doi.org/10.3390/nu8010056
  26. Mazzoli R, Pessione E. The neuro-endocrinological role of microbial glutamate and GABA signaling. Front Microbiol. 2016;7:1934. https://doi.org/10.3389/fmicb.2016.01934
  27. Zhang L, Wu W, Lee YK, Xie J, Zhang H. Spatial heterogeneity and co-occurrence of mucosal and luminal microbiome across swine intestinal tract. Front Microbiol. 2018;9:48. https://doi.org/10.3389/fmicb.2018.00048
  28. Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut microbiome. Curr Opin Gastroenterol. 2014;30:332-8. https://doi.org/10.1097/MOG.0000000000000057
  29. Scott KP, Duncan SH, Flint HJ. Dietary fibre and the gut microbiota. Nutr Bull. 2008;33:201-11. https://doi.org/10.1111/j.1467-3010.2008.00706.x
  30. O'Grady J, O'Connor EM, Shanahan F. Review article: dietary fibre in the era of microbiome science. Aliment Pharmacol Ther. 2019;49:506-15. https://doi.org/10.1111/apt.15129
  31. Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients. 2015;7:2839-49. https://doi.org/10.3390/nu7042839
  32. Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM. Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. mBio. 2019;10:e02566-18. https://doi.org/10.1128/mBio.02566-18
  33. Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017;8:172-84. https://doi.org/10.1080/19490976.2017.1290756
  34. Luise D, Chalvon-Demersay T, Lambert W, Bosi P, Trevisi P. Meta-analysis to evaluate the impact of the reduction of dietary crude protein on the gut health of post-weaning pigs. Ital J Anim Sci. 2021;20:1386-97. https://doi.org/10.1080/1828051X.2021.1952911
  35. Tamanai-Shacoori Z, Smida I, Bousarghin L, Loreal O, Meuric V, Fong SB, et al. Roseburia spp.: a marker of health? Future Microbiol. 2017;12:157-70. https://doi.org/10.2217/fmb2016-0130
  36. Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, et al. Blautia-a new functional genus with potential probiotic properties? Gut Microbes. 2021;13:1875796. https://doi.org/10.1080/19490976.2021.1875796
  37. Biddle A, Stewart L, Blanchard J, Leschine S. Untangling the genetic basis of fibrolytic specialization by lachnospiraceae and ruminococcaceae in diverse gut communities. Diversity. 2013;5:627-40. https://doi.org/10.3390/d5030627
  38. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19:29-41. https://doi.org/10.1111/1462-2920.13589
  39. Zhu Z, Zhu L, Jiang L. Dynamic regulation of gut Clostridium-derived short-chain fatty acids. Trends Biotechnol. 2022;40:266-70. https://doi.org/10.1016/j.tibtech.2021.10.005
  40. Parada Venegas D, De la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277. https://doi.org/10.3389/fimmu.2019.00277
  41. den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, et al. Shortchain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;64:2398-408. https://doi.org/10.2337/db14-1213
  42. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003;62:67-72. https://doi.org/10.1079/pns2002207
  43. Liu WC, Ye M, Liao JH, Zhao ZH, Kim IH, An LL. Application of complex probiotics in swine nutrition - a review. Ann Anim Sci. 2018;18:335-50. https://doi.org/10.2478/aoas2018-0005
  44. Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 2000;66:1654-61. https://doi.org/10.1128/aem.66.4.1654-1661.2000
  45. Mishiro T, Kusunoki R, Otani A, Ansary MMU, Tongu M, Harashima N, et al. Butyric acid attenuates intestinal inflammation in murine DSS-induced colitis model via milk fat globuleEGF factor 8. Lab Invest. 2013;93:834-43. https://doi.org/10.1038/labinvest.2013.70
  46. Liu Y. Fatty acids, inflammation and intestinal health in pigs. J Anim Sci Biotechnol. 2015;6:41. https://doi.org/10.1186/s40104-015-0040-1
  47. Zhong X, Zhang Z, Wang S, Cao L, Zhou L, Sun A, et al. Microbial-driven butyrate regulates jejunal homeostasis in piglets during the weaning stage. Front Microbiol. 2019;9:3335. https://doi.org/10.3389/fmicb.2018.03335
  48. Han Y, Zhao Q, Tang C, Li Y, Zhang K, Li F, et al. Butyrate mitigates weanling piglets from lipopolysaccharide-induced colitis by regulating microbiota and energy metabolism of the gut-liver axis. Front Microbiol. 2020;11:588666. https://doi.org/10.3389/fmicb.2020.588666
  49. Grilli E, Tugnoli B, Foerster CJ, Piva A. Butyrate modulates inflammatory cytokines and tight junctions components along the gut of weaned pigs. J Anim Sci. 2016;94:433-6. https://doi.org/10.2527/jas.2015-9787
  50. Zhang Y, Chen H, Zhu W, Yu K. Cecal infusion of sodium propionate promotes intestinal development and jejunal barrier function in growing pigs. Animals. 2019;9:284. https://doi.org/10.3390/ani9060284
  51. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569-73. https://doi.org/10.1126/science.1241165
  52. Xu M, Jiang Z, Wang C, Li N, Bo L, Zha Y, et al. Acetate attenuates inflammasome activation through GPR43-mediated Ca2+-dependent NLRP3 ubiquitination. Exp Mol Med. 2019;51:1-13. https://doi.org/10.1038/s12276-019-0276-5
  53. Reyer H, Oster M, McCormack UM, Murani E, Gardiner GE, Ponsuksili S, et al. Host-microbiota interactions in ileum and caecum of pigs divergent in feed efficiency contribute to nutrient utilization. Microorganisms. 2020;8:563. https://doi.org/10.3390/microorganisms8040563
  54. McCormack UM, Curiao T, Buzoianu SG, Prieto ML, Ryan T, Varley P, et al. Exploring a possible link between the intestinal microbiota and feed efficiency in pigs. Appl Environ Microbiol. 2017;83:e00380-17. https://doi.org/10.1128/AEM.00380-17
  55. Jiao A, Diao H, Yu B, He J, Yu J, Zheng P, et al. Infusion of short chain fatty acids in the ileum improves the carcass traits, meat quality and lipid metabolism of growing pigs. Anim Nutr. 2021;7:94-100. https://doi.org/10.1016/j.aninu.2020.05.009
  56. Gilbert MS, Ijssennagger N, Kies AK, van Mil SWC. Protein fermentation in the gut; implications for intestinal dysfunction in humans, pigs, and poultry. Am J Physiol Gastrointest Liver Physiol. 2018;315:G159-70. https://doi.org/10.1152/ajpgi.00319.2017
  57. Ran-Ressler RR, Glahn RP, Bae S, Brenna JT. Branched-chain fatty acids in the neonatal gut and estimated dietary intake in infancy and adulthood. In: The Importance of Immunonutrition: 77th Nestle Nutrition Institute Workshop; 2013; Panama. p. 133-43.
  58. Ran-Ressler RR, Khailova L, Arganbright KM, Adkins-Rieck CK, Jouni ZE, Koren O, et al. Branched chain fatty acids reduce the incidence of necrotizing enterocolitis and alter gastrointestinal microbial ecology in a neonatal rat model. PLOS ONE. 2011;6:e29032. https://doi.org/10.1371/journal.pone.0029032
  59. Boudry G, Jamin A, Chatelais L, Gras-Le Guen C, Michel C, Le Huerou-Luron I. Dietary protein excess during neonatal life alters colonic microbiota and mucosal response to inflammatory mediators later in life in female pigs. J Nutr. 2013;143:1225-32. https://doi.org/10.3945/jn.113.175828
  60. Pieper R, Villodre Tudela C, Taciak M, Bindelle J, Perez JF, Zentek J. Health relevance of intestinal protein fermentation in young pigs. Anim Health Res Rev. 2016;17:137-47. https://doi.org/10.1017/S1466252316000141
  61. Rios-Covian D, Gonzalez S, Nogacka AM, Arboleya S, Salazar N, Gueimonde M, et al. An overview on fecal branched short-chain fatty acids along human life and as related with body mass index: associated dietary and anthropometric factors. Front Microbiol. 2020;11:973. https://doi.org/10.3389/fmicb.2020.00973
  62. Rist VTS, Weiss E, Eklund M, Mosenthin R. Impact of dietary protein on microbiota composition and activity in the gastrointestinal tract of piglets in relation to gut health: a review. Animal. 2013;7:1067-78. https://doi.org/10.1017/S1751731113000062
  63. Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 2006;72:3593-9. https://doi.org/10.1128/AEM.72.5.3593-3599.2006
  64. Brestensky M, Nitrayova S, Bomba A, Patras P, Strojny L, Szabadosova V, et al. The content of short chain fatty acids in the jejunal digesta, caecal digesta and faeces of growing pigs. Livest Sci. 2017;205:106-10. https://doi.org/10.1016/j.livsci.2017.09.015
  65. Fiorucci S, Mencarelli A, Palladino G, Cipriani S. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci. 2009;30:570-80. https://doi.org/10.1016/j.tips.2009.08.001
  66. Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharma Sin B. 2015;5:135-44. https://doi.org/10.1016/j.apsb.2015.01.004
  67. Rizzo G, Renga B, Mencarelli A, Pellicciari R, Fiorucci S. Role of FXR in regulating bile acid homeostasis and relevance for human diseases. Curr Drug Targets Immune Endocr Metab Disord. 2005;5:289-303. https://doi.org/10.2174/1568008054863781
  68. Lin S, Yang X, Yuan P, Yang J, Wang P, Zhong H, et al. Undernutrition shapes the gut microbiota and bile acid profile in association with altered gut-liver FXR signaling in weaning pigs. J Agric Food Chem. 2019;67:3691-701. https://doi.org/10.1021/acs.jafc.9b01332
  69. Lin S, Yang X, Long Y, Zhong H, Wang P, Yuan P, et al. Dietary supplementation with Lactobacillus plantarum modified gut microbiota, bile acid profile and glucose homoeostasis in weaning piglets. Br J Nutr. 2020;124:797-808. https://doi.org/10.1017/S0007114520001774
  70. Song M, Yang Q, Zhang F, Chen L, Su H, Yang X, et al. Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria. FASEB J. 2020;34:7103-17. https://doi.org/10.1096/fj.201903244R
  71. Gruner N, Mattner J. Bile acids and microbiota: multifaceted and versatile regulators of the liver-gut axis. Int J Mol Sci. 2021;22:1397. https://doi.org/10.3390/ijms22031397
  72. Wylensek D, Hitch TCA, Riedel T, Afrizal A, Kumar N, Wortmann E, et al. A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity. Nat Commun. 2020;11:6389. https://doi.org/10.1038/s41467-020-19929-w
  73. Ni Dhonnabhain R, Xiao Q, O'Malley D. Aberrant gut-to-brain signaling in irritable bowel syndrome - the role of bile acids. Front Endocrinol. 2021;12:745190. https://doi.org/10.3389/fendo.2021.745190
  74. Zhan K, Zheng H, Li J, Wu H, Qin S, Luo L, et al. Gut microbiota-bile acid crosstalk in diarrhea-irritable bowel syndrome. BioMed Res Int. 2020;2020:3828249. https://doi.org/10.1155/2020/3828249
  75. Matsumoto M, Benno Y. The relationship between microbiota and polyamine concentration in the human intestine: a pilot study. Microbiol Immunol. 2013;51:25-35. https://doi.org/10.1111/j.1348-0421.2007.tb03887.x
  76. Tofalo R, Cocchi S, Suzzi G. Polyamines and gut microbiota. Front Nutr. 2019;6:16. https://doi.org/10.3389/fnut.2019.00016
  77. Ramos-Molina B, Queipo-Ortuno MI, Lambertos A, Tinahones FJ, Penafiel R. Dietary and gut microbiota polyamines in obesity- and age-related diseases. Front Nutr. 2019;6:24. https://doi.org/10.3389/fnut.2019.00024
  78. Sabater-Molina M, Larque E, Torrella F, Plaza J, Ramis G, Zamora S. Effects of fructooligosaccharides on cecum polyamine concentration and gut maturation in earlyweaned piglets. J Clin Biochem Nutr. 2011;48:230-6. https://doi.org/10.3164/jcbn.10-100
  79. Sabater-Molina M, Larque E, Torrella F, Plaza J, Lozano T, Munoz A, et al. Effects of dietary polyamines at physiologic doses in early-weaned piglets. Nutrition. 2009;25:940-6. https://doi.org/10.1016/j.nut.2009.01.017
  80. Tan C, Huang Z, Xiong W, Ye H, Deng J, Yin Y. A review of the amino acid metabolism in placental function response to fetal loss and low birth weight in pigs. J Anim Sci Biotechnol. 2022;13:28. https://doi.org/10.1186/s40104-022-00676-5
  81. Wu G, Bazer FW, Hu J, Johnson GA, Spencer TE. Polyamine synthesis from proline in the developing porcine placenta. Biol Reprod. 2005;72:842-50. https://doi.org/10.1095/biolreprod.104.036293
  82. Fang T, Liu G, Cao W, Wu X, Jia G, Zhao H, et al. Spermine: new insights into the intestinal development and serum antioxidant status of suckling piglets. RSC Adv. 2016;6:31323-35. https://doi.org/10.1039/c6ra05361k
  83. van Wettere WHEJ, Willson NL, Pain SJ, Forder REA. Effect of oral polyamine supplementation pre-weaning on piglet growth and intestinal characteristics. Animal. 2016;10:1655-9. https://doi.org/10.1017/S1751731116000446
  84. Gierse LC, Meene A, Schultz D, Schwaiger T, Karte C, Schroder C, et al. A multi-omics protocol for swine feces to elucidate longitudinal dynamics in microbiome structure and function. Microorganisms. 2020;8:1887. https://doi.org/10.3390/microorganisms8121887
  85. Ewtushik AL, Bertolo RFP, Ball RO. Intestinal development of early-weaned piglets receiving diets supplemented with selected amino acids or polyamines. Can J Anim Sci. 2000;80:653-62. https://doi.org/10.4141/A99-134
  86. Ma Y, Han X, Fang J, Jiang H. Role of dietary amino acids and microbial metabolites in the regulation of pig intestinal health. Anim Nutr. 2022;9:1-6. https://doi.org/10.1016/j.aninu.2021.10.004
  87. Davila AM, Blachier F, Gotteland M, Andriamihaja M, Benetti PH, Sanz Y, et al. Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. Pharmacol Res. 2013;68:95-107. https://doi.org/10.1016/j.phrs.2012.11.005
  88. Zhao J, Zhang X, Liu H, Brown MA, Qiao S. Dietary protein and gut microbiota composition and function. Curr Protein Pept Sci. 2019;20:145-54. https://doi.org/10.2174/1389203719666180514145437
  89. Dodd D, Spitzer MH, van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551:648-52. https://doi.org/10.1038/nature24661
  90. Wlodarska M, Luo C, Kolde R, d'Hennezel E, Annand JW, Heim CE, et al. Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation. Cell Host Microbe. 2017;22:25-37.E6. https://doi.org/10.1016/j.chom.2017.06.007
  91. Shimada Y, Kinoshita M, Harada K, Mizutani M, Masahata K, Kayama H, et al. Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLOS ONE. 2013;8:e80604. https://doi.org/10.1371/journal.pone.0080604
  92. Li X, Zhang B, Hu Y, Zhao Y. New insights into gut-bacteria-derived indole and its derivatives in intestinal and liver diseases. Front Pharmacol. 2021;12:769501. https://doi.org/10.3389/fphar.2021.769501
  93. Andriamihaja M, Lan A, Beaumont M, Audebert M, Wong X, Yamada K, et al. The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells. Free Radic Biol Med. 2015;85:219-27. https://doi.org/10.1016/j.freeradbiomed.2015.04.004
  94. Windey K, De Preter V, Verbeke K. Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2011;56:184-96. https://doi.org/10.1002/mnfr.201100542
  95. Liang H, Dai Z, Liu N, Ji Y, Chen J, Zhang Y, et al. Dietary L-tryptophan modulates the structural and functional composition of the intestinal microbiome in weaned piglets. Front Microbiol. 2018;9:1736. https://doi.org/10.3389/fmicb.2018.01736
  96. Fu Q, Tan Z, Shi L, Xun W. Resveratrol attenuates diquat-induced oxidative stress by regulating gut microbiota and metabolome characteristics in piglets. Front Microbiol. 2021;12:695155. https://doi.org/10.3389/fmicb.2021.695155
  97. Wesoly R, Weiler U. Nutritional influences on skatole formation and skatole metabolism in the pig. Animals. 2012;2:221-42. https://doi.org/10.3390/ani2020221
  98. Jensen BB. Prevention of boar taint in pig production. Factors affecting the level of skatole. Acta Vet Scand. 2006;48:S6. https://doi.org/10.1186/1751-0147-48-S1-S6
  99. Pieper R, Boudry C, Bindelle J, Vahjen W, Zentek J. Interaction between dietary protein content and the source of carbohydrates along the gastrointestinal tract of weaned piglets. Arch Anim Nutr. 2014;68:263-80. https://doi.org/10.1080/1745039X.2014.932962
  100. De Bruyne E, Ducatelle R, Foss D, Sanchez M, Joosten M, Zhang G, et al. Oral glutathione supplementation drastically reduces Helicobacter-induced gastric pathologies. Sci Rep. 2016;6:20169. https://doi.org/10.1038/srep20169
  101. Zhang G, Ducatelle R, Pasmans F, D'Herde K, Huang L, Smet A, et al. Effects of helicobacter suis γ- glutamyl transpeptidase on lymphocytes: modulation by glutamine and glutathione supplementation and outer membrane vesicles as a putative delivery route of the enzyme. PLOS ONE 2014;9:e77966. https://doi.org/10.1371/journal.pone.0077966
  102. Blachier F, Beaumont M, Kim E. Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin. Curr Opin Clin Nutr Metab Care. 2019;22:68-75. https://doi.org/10.1097/MCO.0000000000000526
  103. Blachier F, Andriamihaja M, Kong XF. Fate of undigested proteins in the pig large intestine: what impact on the colon epithelium? Anim Nutr. 2022;9:110-8. https://doi.org/10.1016/j.aninu.2021.08.001
  104. Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693:128-33. https://doi.org/10.1016/j.brainres.2018.03.015
  105. Kobek-Kjeldager C, Schonherz AA, Canibe N, Pedersen LJ. Diet and microbiota-gut-brain axis in relation to tail biting in pigs: a review. Appl Anim Behav Sci. 2022;246:105514. https://doi.org/10.1016/j.applanim.2021.105514
  106. Henry Y, Seve B, Mounier A, Ganier P. Growth performance and brain neurotransmitters in pigs as affected by tryptophan, protein, and sex. J Anim Sci. 1996;74:2700-10. https://doi.org/10.2527/1996.74112700x
  107. Saraf MK, Piccolo BD, Bowlin AK, Mercer KE, LeRoith T, Chintapalli SV, et al. Formula diet driven microbiota shifts tryptophan metabolism from serotonin to tryptamine in neonatal porcine colon. Microbiome. 2017;5:77. https://doi.org/10.1186/s40168-017-0297-z
  108. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24:160-8. https://doi.org/10.1016/j.copbio.2012.08.005
  109. LeBlanc JG, Laino JE, del Valle MJ, Vannini V, van Sinderen D, Taranto MP, et al. B-group vitamin production by lactic acid bacteria - current knowledge and potential applications. J Appl Microbiol. 2011;111:1297-309. https://doi.org/10.1111/j.1365-2672.2011.05157.x
  110. Caspani G, Swann J. Small talk: microbial metabolites involved in the signaling from microbiota to brain. Curr Opin Pharmacol. 2019;48:99-106. https://doi.org/10.1016/j.coph.2019.08.001
  111. Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol. 2020;11:25. https://doi.org/10.3389/fendo.2020.00025
  112. Rios-Covian D, Ruas-Madiedo P, Margolles A, Gueimonde M, de los Reyes-Gavilan CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 2016;7:185. https://doi.org/10.3389/fmicb.2016.00185
  113. Makki K, Deehan EC, Walter J, Backhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23:705-15. https://doi.org/10.1016/j.chom.2018.05.012
  114. Trefflich I, Dietrich S, Braune A, Abraham K, Weikert C. Short- and branched-chain fatty acids as fecal markers for microbiota activity in vegans and omnivores. Nutrients. 2021;13:1808. https://doi.org/10.3390/nu13061808
  115. Macfarlane GT, Gibson GR, Beatty E, Cummings JH. Estimation of short-chain fatty acid production from protein by human intestinal bacteria based on branched-chain fatty acid measurements. FEMS Microbiol Lett. 1992;101:81-8. https://doi.org/10.1111/j.1574-6968.1992.tb05764.x
  116. Nakatani M, Inoue R, Tomonaga S, Fukuta K, Tsukahara T. Production, absorption, and blood flow dynamics of short-chain fatty acids produced by fermentation in piglet hindgut during the suckling-weaning period. Nutrients. 2018;10:1220. https://doi.org/10.3390/nu10091220
  117. Miller TL, Wolin MJ. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol. 1996;62:1589-92. https://doi.org/10.1128/aem.62.5.1589-1592.1996
  118. Ragsdale SW, Pierce E. Acetogenesis and the Wood-Ljungdahl pathway of CO2 fixation. Biochim Biophys Acta Proteins Proteom. 2008;1784:1873-98. https://doi.org/10.1016/j.bbapap.2008.08.012
  119. Bai Y, Zhou X, Zhao J, Wang Z, Ye H, Pi Y, et al. Sources of dietary fiber affect the SCFA production and absorption in the hindgut of growing pigs. Front Nutr. 2022;8:719935. https://doi.org/10.3389/fnut.2021.719935
  120. Namkung H, Li M, Gong J, Yu H, Cottrill M, de Lange CFM. Impact of feeding blends of organic acids and herbal extracts on growth performance, gut microbiota and digestive function in newly weaned pigs. Can J Anim Sci. 2004;84:697-704. https://doi.org/10.4141/A04-005
  121. Dotsenko G, Meyer AS, Canibe N, Thygesen A, Nielsen MK, Lange L. Enzymatic production of wheat and ryegrass derived xylooligosaccharides and evaluation of their in vitro effect on pig gut microbiota. Biomass Convers Biorefin. 2018;8:497-507. https://doi.org/10.1007/s13399-017-0298-y
  122. Oh JK, Vasquez R, Kim SH, Hwang IC, Song JH, Park JH, et al. Multispecies probiotics alter fecal short-chain fatty acids and lactate levels in weaned pigs by modulating gut microbiota. J Anim Sci Technol. 2021;63:1142-58. https://doi.org/10.5187/jast.2021.e94
  123. Liu H, Wang J, He T, Becker S, Zhang G, Li D, et al. Butyrate: a double-edged sword for health? Adv Nutr. 2018;9:21-9. https://doi.org/10.1093/advances/nmx009
  124. Yu K, Zhang Y, Chen H, Zhu W. Hepatic metabolomic and transcriptomic responses induced by cecal infusion of sodium propionate in a fistula pig model. J Agric Food Chem. 2019;67:13073-81. https://doi.org/10.1021/acs.jafc.9b05070
  125. Zeng H, Chi H. Metabolic control of regulatory T cell development and function. Trends Immunol. 2015;36:3-12. https://doi.org/10.1016/j.it.2014.08.003
  126. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775-87. https://doi.org/10.1016/j.cell.2008.05.009
  127. Kondelkova K, Vokurkova D, Krejsek J, Borska L, Fiala Z, Ctirad A. Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Medica (Hradec Kralove) Universitas Carolina, Facultas Medica Hradec Kralove 2010;53:73-7. https://doi.org/10.14712/18059694.2016.63
  128. Zhang H, van der Wielen N, van der Hee B, Wang J, Hendriks W, Gilbert M. Impact of fermentable protein, by feeding high protein diets, on microbial composition, microbial catabolic activity, gut health and beyond in pigs. Microorganisms. 2020;8:1735. https://doi.org/10.3390/microorganisms8111735
  129. Heo JM, Kim JC, Hansen CF, Mullan BP, Hampson DJ, Pluske JR. Feeding a diet with a decreased protein content reduces both nitrogen content in the gastrointestinal tract and post-weaning diarrhoea, but does not affect apparent nitrogen digestibility in weaner pigs challenged with an enterotoxigenic strain of Escherichia coli. Anim Feed Sci Technol. 2010;160:148-59. https://doi.org/10.1016/j.anifeedsci.2010.07.005
  130. He X, Sun W, Ge T, Mu C, Zhu W. An increase in corn resistant starch decreases protein fermentation and modulates gut microbiota during in vitro cultivation of pig large intestinal inocula. Anim Nutr. 2017;3:219-24. https://doi.org/10.1016/j.aninu.2017.06.004
  131. Cho HM, Gonzalez-Ortiz G, Melo-Duran D, Heo JM, Cordero G, Bedford MR, et al. Stimbiotic supplementation improved performance and reduced inflammatory response via stimulating fiber fermenting microbiome in weaner pigs housed in a poor sanitary environment and fed an antibiotic-free low zinc oxide diet. PLOS ONE. 2020;15:e0240264. https://doi.org/10.1371/journal.pone.0240264
  132. Wang J, Ji H. Influence of probiotics on dietary protein digestion and utilization in the gastrointestinal tract. Curr Protein Pept Sci. 2019;20:125-31. https://doi.org/10.2174/1389203719666180517100339
  133. Zeng H, Umar S, Rust B, Lazarova D, Bordonaro M. Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer. Int J Mol Sci. 2019;20:1214. https://doi.org/10.3390/ijms20051214
  134. Molinero N, Ruiz L, Sanchez B, Margolles A, Delgado S. Intestinal bacteria interplay with bile and cholesterol metabolism: implications on host physiology. Front Physiol. 2019;10:185. https://doi.org/10.3389/fphys.2019.00185
  135. Jones ML, Tomaro-Duchesneau C, Prakash S. The gut microbiome, probiotics, bile acids axis, and human health. Trends Microbiol. 2014;22:306-8. https://doi.org/10.1016/j.tim.2014.04.010
  136. Fan P, Song P, Li L, Huang C, Chen J, Yang W, et al. Roles of biogenic amines in intestinal signaling. Curr Protein Pept Sci. 2017;18:532-40. https://doi.org/10.2174/1389203717666160627073048
  137. Wu G, Bazer FW, Hu J, Johnson GA, Spencer TE. Polyamine synthesis from proline in the developing porcine placenta. Biol Reprod. 2005;72:842-50. https://doi.org/10.1095/biolreprod.104.036293
  138. Nakamura A, Ooga T, Matsumoto M. Intestinal luminal putrescine is produced by collective biosynthetic pathways of the commensal microbiome. Gut Microbes. 2019;10:159-71. https://doi.org/10.1080/19490976.2018.1494466
  139. Bekebrede AF, Keijer J, Gerrits WJJ, de Boer VCJ. The molecular and physiological effects of protein-derived polyamines in the intestine. Nutrients. 2020;12:197. https://doi.org/10.3390/nu12010197
  140. Yu D, Zhu W, Hang S. Effects of long-term dietary protein restriction on intestinal morphology, digestive enzymes, gut hormones, and colonic microbiota in pigs. Animals. 2019;9:180. https://doi.org/10.3390/ani9040180
  141. Chen X, Song P, Fan P, He T, Jacobs D, Levesque CL, et al. Moderate dietary protein restriction optimized gut microbiota and mucosal barrier in growing pig model. Front Cell Infect Microbiol. 2018;8:246. https://doi.org/10.3389/fcimb.2018.00246
  142. Zhang C, Yu M, Yang Y, Mu C, Su Y, Zhu W. Effect of early antibiotic administration on cecal bacterial communities and their metabolic profiles in pigs fed diets with different protein levels. Anaerobe. 2016;42:188-96. https://doi.org/10.1016/j.anaerobe.2016.10.016
  143. Yu M, Zhang C, Yang Y, Mu C, Su Y, Yu K, et al. Long-term effects of early antibiotic intervention on blood parameters, apparent nutrient digestibility, and fecal microbial fermentation profile in pigs with different dietary protein levels. J Anim Sci Biotechnol. 2017;8:60. https://doi.org/10.1186/s40104-017-0192-2
  144. Peng Y, Yu K, Mu C, Hang S, Che L, Zhu W. Progressive response of large intestinal bacterial community and fermentation to the stepwise decrease of dietary crude protein level in growing pigs. Appl Microbiol Biotechnol. 2017;101:5415-26. https://doi.org/10.1007/s00253-017-8285-6
  145. Wang J, Tan B, Li J, Kong X, Tan M, Wu G. Regulatory role of L-proline in fetal pig growth and intestinal epithelial cell proliferation. Anim Nutr. 2020;6:438-46. https://doi.org/10.1016/j.aninu.2020.07.001
  146. Liu B, Jiang X, Cai L, Zhao X, Dai Z, Wu G, et al. Putrescine mitigates intestinal atrophy through suppressing inflammatory response in weanling piglets. J Anim Sci Biotechnol. 2019;10:69. https://doi.org/10.1186/s40104-019-0379-9
  147. Smith EA, Macfarlane GT. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb Ecol. 1997;33:180-8. https://doi.org/10.1007/s002489900020
  148. Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Tolllike receptor 4. Immunity. 2014;41:296-310. https://doi.org/10.1016/j.immuni.2014.06.014
  149. Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23:716-24. https://doi.org/10.1016/j.chom.2018.05.003
  150. Liang H, Dai Z, Kou J, Sun K, Chen J, Yang Y, et al. Dietary L-tryptophan supplementation enhances the intestinal mucosal barrier function in weaned piglets: implication of tryptophanmetabolizing microbiota. Int J Mol Sci. 2019;20:20. https://doi.org/10.3390/ijms20010020
  151. Kong XF, Ji YJ, Li HW, Zhu Q, Blachier F, Geng MM, et al. Colonic luminal microbiota and bacterial metabolite composition in pregnant Huanjiang mini-pigs: effects of food composition at different times of pregnancy. Sci Rep. 2016;6:37224. https://doi.org/10.1038/srep37224
  152. Li R, Hou G, Jiang X, Song Z, Fan Z, Hou DX, et al. Different dietary protein sources in low protein diets regulate colonic microbiota and barrier function in a piglet model. Food Funct. 2019;10:6417-28. https://doi.org/10.1039/c9fo01154d
  153. Arroyo L, Carreras R, Valent D, Pena R, Mainau E, Velarde A, et al. Effect of handling on neurotransmitter profile in pig brain according to fear related behaviour. Physiol Behav. 2016;167:374-81. https://doi.org/10.1016/j.physbeh.2016.10.005
  154. Moeser AJ, Pohl CS, Rajput M. Weaning stress and gastrointestinal barrier development: implications for lifelong gut health in pigs. Anim Nutr. 2017;3:313-21. https://doi.org/10.1016/j.aninu.2017.06.003
  155. Lyte JM, Lyte M. Review: microbial endocrinology: intersection of microbiology and neurobiology matters to swine health from infection to behavior. Animal. 2019;13:2689-98. https://doi.org/10.1017/S1751731119000284
  156. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264-76. https://doi.org/10.1016/j.cell.2015.02.047
  157. Kwon YH, Wang H, Denou E, Ghia JE, Rossi L, Fontes ME, et al. Modulation of gut microbiota composition by serotonin signaling influences intestinal immune response and susceptibility to colitis. Cell Mol Gastroenterol Hepatol. 2019;7:709-28. https://doi.org/10.1016/j.jcmgh.2019.01.004
  158. Li ZS, Schmauss C, Cuenca A, Ratcliffe E, Gershon MD. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J Neurosci. 2006;26:2798-807. https://doi.org/10.1523/JNEUROSCI.4720-05.2006
  159. Gao K, Pi Y, Mu CL, Peng Y, Huang Z, Zhu WY. Antibiotics-induced modulation of large intestinal microbiota altered aromatic amino acid profile and expression of neurotransmitters in the hypothalamus of piglets. J Neurochem. 2018;146:219-34. https://doi.org/10.1111/jnc.14333
  160. Hu J, Nie Y, Chen J, Zhang Y, Wang Z, Fan Q, et al. Gradual changes of gut microbiota in weaned miniature piglets. Front Microbiol. 2016;7:1727. https://doi.org/10.3389/fmicb.2016.01727
  161. LeBlanc JG, Chain F, Martin R, Bermudez-Humaran LG, Courau S, Langella P. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact. 2017;16:79. https://doi.org/10.1186/s12934-017-0691-z
  162. Lauridsen C, Matte JJ, Lessard M, Celi P, Litta G. Role of vitamins for gastro-intestinal functionality and health of pigs. Anim Feed Sci Technol. 2021;273:114823. https://doi.org/10.1016/j.anifeedsci.2021.114823
  163. Yoshii K, Hosomi K, Sawane K, Kunisawa J. Metabolism of dietary and microbial vitamin b family in the regulation of host immunity. Front Nutr. 2019;6:48. https://doi.org/10.3389/fnut.2019.00048
  164. Liao SF, Nyachoti M. Using probiotics to improve swine gut health and nutrient utilization. Anim Nutr. 2017;3:331-43. https://doi.org/10.1016/j.aninu.2017.06.007
  165. Roselli M, Pieper R, Rogel-Gaillard C, de Vries H, Bailey M, Smidt H, et al. Immunomodulating effects of probiotics for microbiota modulation, gut health and disease resistance in pigs. Anim Feed Sci Technol. 2017;233:104-19. https://doi.org/10.1016/j.anifeedsci.2017.07.011
  166. Mun D, Kyoung H, Kong M, Ryu S, Jang KB, Baek J, et al. Effects of Bacillus-based probiotics on growth performance, nutrient digestibility, and intestinal health of weaned pigs. J Anim Sci Technol. 2021;63:1314-27. https://doi.org/10.5187/jast.2021.e109
  167. Bugenyi AW, Cho HS, Heo J. Association between oropharyngeal microbiome and weight gain in piglets during pre and post weaning life. J Anim Sci Technol. 2020;62:247-62. https://doi.org/10.5187/jast.2020.62.2.247
  168. Kwon MS, Jo HE, Lee J, Choi KS, Yu D, Oh YS, et al. Alteration of the gut microbiota in post-weaned calves following recovery from bovine coronavirus-mediated diarrhea. J Anim Sci Technol. 2021;61:125-36.
  169. Wang K, Hu C, Tang W, Azad MAK, Zhu Q, He Q, et al. The enhancement of intestinal immunity in offspring piglets by maternal probiotic or synbiotic supplementation is associated with the alteration of gut microbiota. Front Nutr. 2021;8:686053. https://doi.org/10.3389/fnut.2021.686053
  170. Barba-Vidal E, Martin-Orue SM, Castillejos L. Review: are we using probiotics correctly in post-weaning piglets? Animal. 2018;12:2489-98. https://doi.org/10.1017/S1751731118000873
  171. Liu H, Hou C, Wang G, Jia H, Yu H, Zeng X, et al. Lactobacillus reuteri I5007 modulates intestinal host defense peptide expression in the model of IPEC-J2 cells and neonatal piglets. Nutrients. 2017;9:559. https://doi.org/10.3390/nu9060559
  172. Lu X, Zhang M, Zhao L, Ge K, Wang Z, Jun L, et al. Growth performance and post-weaning diarrhea in piglets fed a diet supplemented with probiotic complexes. J Microbiol Biotechnol. 2018;28:1791-9. https://doi.org/10.4014/jmb.1807.07026
  173. Andersen AD, Nguyen DN, Langhorn L, Renes IB, van Elburg RM, Hartog A, et al. Synbiotics combined with glutamine stimulate brain development and the immune system in preterm pigs. J Nutr. 2019;149:36-45. https://doi.org/10.1093/jn/nxy243
  174. Cao G, Tao F, Hu Y, Li Z, Zhang Y, Deng B, et al. Positive effects of a Clostridium butyricum-based compound probiotic on growth performance, immune responses, intestinal morphology, hypothalamic neurotransmitters, and colonic microbiota in weaned piglets. Food Funct. 2019;10:2926-34. https://doi.org/10.1039/c8fo02370k
  175. Wang S, Yao B, Gao H, Zang J, Tao S, Zhang S, et al. Combined supplementation of Lactobacillus fermentum and Pediococcus acidilactici promoted growth performance, alleviated inflammation, and modulated intestinal microbiota in weaned pigs. BMC Vet Res. 2019;15:239. https://doi.org/10.1186/s12917-019-1991-9
  176. Ding H, Zhao X, Ma C, Gao Q, Yin Y, Kong X, et al. Dietary supplementation with Bacillus subtilis DSM 32315 alters the intestinal microbiota and metabolites in weaned piglets. J Appl Microbiol. 2021;130:217-32. https://doi.org/10.1111/jam.14767
  177. Wang X, Tian Z, Azad MAK, Zhang W, Blachier F, Wang Z, et al. Dietary supplementation with Bacillus mixture modifies the intestinal ecosystem of weaned piglets in an overall beneficial way. J Appl Microbiol. 2021;130:233-46. https://doi.org/10.1111/jam.14782
  178. Wang XL, Liu ZY, Li YH, Yang LY, Yin J, He JH, et al. Effects of dietary supplementation of Lactobacillus delbrueckii on gut microbiome and intestinal morphology in weaned piglets. Front Vet Sci. 2021;8:692389. https://doi.org/10.3389/fvets.2021.692389
  179. Lu X, Zhang M, Zhao L, Ge K, Wang Z, Jun L, et al. Growth performance and post-weaning diarrhea in piglets fed a diet supplemented with probiotic complexes. J Microbiol Biotechnol. 2018;28:1791-9. https://doi.org/10.4014/jmb.1807.07026
  180. Ma C, Azad MAK, Tang W, Zhu Q, Wang W, Gao Q, et al. Maternal probiotics supplementation improves immune and antioxidant function in suckling piglets via modifying gut microbiota. J Appl Microbiol. 2022. https://doi.org/10.1111/jam.15572
  181. He T, Zhu YH, Yu J, Xia B, Liu X, Yang GY, et al. Lactobacillus johnsonii L531 reduces pathogen load and helps maintain short-chain fatty acid levels in the intestines of pigs challenged with Salmonella enterica infantis. Vet Microbiol. 2019;230:187-94. https://doi.org/10.1016/j.vetmic.2019.02.003
  182. Sakata T, Kojima T, Fujieda M, Takahashi M, Michibata T. Influences of probiotic bacteria on organic acid production by pig caecal bacteria in vitro. Proc Nutr Soc. 2003;62:73-80. https://doi.org/10.1079/pns2002211
  183. Ohashi Y, Ushida K. Health-beneficial effects of probiotics: its mode of action. Anim Sci J. 2009;80:361-71. https://doi.org/10.1111/j.1740-0929.2009.00645.x
  184. El Aidy S, Merrifield CA, Derrien M, van Baarlen P, Hooiveld G, Levenez F, et al. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut. 2013;62:1306-14. https://doi.org/10.1136/gutjnl-2011-301955
  185. Hou G, Peng W, Wei L, Li R, Yuan Y, Huang X, et al. Lactobacillus delbrueckii interfere with bile acid enterohepatic circulation to regulate cholesterol metabolism of growing-finishing pigs via its bile salt hydrolase activity. Front Nutr. 2020;7:617676. https://doi.org/10.3389/fnut.2020.617676
  186. Nealon NJ, Yuan L, Yang X, Ryan EP. Rice bran and probiotics alter the porcine large intestine and serum metabolomes for protection against human rotavirus diarrhea. Front Microbiol. 2017;8:653. https://doi.org/10.3389/fmicb.2017.00653
  187. Yang M, Gu Y, Li L, Liu T, Song X, Sun Y, et al. Bile acid-gut microbiota axis in inflammatory bowel disease: from bench to bedside. Nutrients. 2021;13:3143. https://doi.org/10.3390/nu13093143
  188. Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep. 2014;7:12-8. https://doi.org/10.1016/j.celrep.2014.02.032
  189. Barba-Vidal E, Castillejos L, Lopez-Colom P, Urgell MR, Moreno Munoz JA, Martin-Orue SM. Evaluation of the probiotic strain Bifidobacterium longum subsp. infantis CECT 7210 capacities to improve health status and fight digestive pathogens in a piglet model. Front Microbiol. 2017;8:533. https://doi.org/10.3389/fmicb.2017.00533
  190. Rodriguez-Sorrento A, Castillejos L, Lopez-Colom P, Cifuentes-Orjuela G, RodriguezPalmero M, Moreno-Munoz JA, et al. Effects of the administration of Bifidobacterium longum subsp. infantis CECT 7210 and Lactobacillus rhamnosus HN001 and their synbiotic combination with galacto-oligosaccharides against enterotoxigenic Escherichia coli F4 in an early weaned piglet model. Front Microbiol. 2021;12:642549. https://doi.org/10.3389/fmicb.2021.642549
  191. Sheng QK, Zhou KF, Hu HM, Zhao HB, Zhang Y, Ying W. Effect of Bacillus subtilis natto on meat quality and skatole content in TOPIGS pigs. Asian-Australas J Anim Sci. 2016;29:716-21. https://doi.org/10.5713/ajas.15.0478
  192. Peng XP, Nie C, Guan WY, Qiao LD, Lu L, Cao SJ. Regulation of probiotics on metabolism of dietary protein in intestine. Curr Protein Pept Sci. 2020;21:766-71. https://doi.org/10.2174/1389203720666191111112941
  193. Yong SJ, Tong T, Chew J, Lim WL. Antidepressive mechanisms of probiotics and their therapeutic potential. Front Neurosci. 2020;13:1361. https://doi.org/10.3389/fnins.2019.01361
  194. Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PWJ. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci. 2016;39:763-81. https://doi.org/10.1016/j.tins.2016.09.002
  195. Cao G, Tao F, Hu Y, Li Z, Zhang Y, Deng B, et al. Positive effects of a: Clostridium butyricum-based compound probiotic on growth performance, immune responses, intestinal morphology, hypothalamic neurotransmitters, and colonic microbiota in weaned piglets. Food Funct. 2019;10:2926-34. https://doi.org/10.1039/c8fo02370k
  196. Valent D, Arroyo L, Fabrega E, Font-i-Furnols M, Rodriguez-Palmero M, Moreno-Munoz JA, et al. Effects of a high-fat-diet supplemented with probiotics and ω3-fatty acids on appetite regulatory neuropeptides and neurotransmitters in a pig model. Benef Microbes. 2020;11:347-59. https://doi.org/10.3920/BM2019.0197
  197. Parois SP, Eicher SD, Lindemann SR, Marchant JN. Potential improvements of the cognition of piglets through a synbiotic supplementation from 1 to 28 days via the gut microbiota. Sci Rep. 2021;11:24113. https://doi.org/10.1038/s41598-021-03565-5
  198. Nowak P, Kasprowicz-Potocka M, Zaworska A, Nowak W, Stefanska B, Sip A, et al. The effect of eubiotic feed additives on the performance of growing pigs and the activity of intestinal microflora. Arch Anim Nutr. 2017;71:455-69. https://doi.org/10.1080/1745039X.2017.1390181
  199. Zhang J, Chen X, Liu P, Zhao J, Sun J, Guan W, et al. Dietary clostridium butyricum induces a phased shift in fecal microbiota structure and increases the acetic acid-producing bacteria in a weaned piglet model. J Agric Food Chem. 2018;66:5157-66. https://doi.org/10.1021/acs.jafc.8b01253